Laserfiche WebLink
E x T o x N E T PIP-SULFUR http://ace.orst.edu/inf'o/cxtoxneupips/sulfur.litm <br /> hundred food and feed crop, ornamental, turf and residential sites. It is also used as a fertilizer or soil <br /> amendment for reclaiming alkaline soils. Sulfur is applied in dust, granular or liquid form, and is an <br /> active ingredient in nearly 300 registered pesticide products (357). <br /> TOXICOLOGICAL EFFECTS <br /> • Acute Toxicity: Sulfur is known to be of low toxicity, and poses very little if any risk to human and <br /> animal health (l, 357). Short-term studies show that sulfur is of very low acute oral toxicity and <br /> does not irritate the skin (it has been placed in EPA Toxicity Category IV, the least toxic category, <br /> for these effects). Sulfur also is not a skin sensitizer. However, it can cause some eye irritation, <br /> dermal toxicity and inhalation hazards (357). When taken orally, it has a mild laxative action (1). It <br /> may cause irritation of skin and the mucous membranes. Sulfur is considered a skin and eye irritant <br /> (1, 242, 223, 207). Acute exposure inhalation of large amounts of the dust may cause catarrhal <br /> inflammation of the nasal mucosa which may lead to hyperplasia with abundant nasal secretions. <br /> Trachiobronchitis is a frequent occurrence, with dyspnea, persistent cough and expectoration which <br /> may sometimes be streaked with blood (354). Sulfur was reported to have a rat oral LD50 of greater <br /> than 5,000 mg/kg (223, 359); and greater than 8,437 mg/kg (354). Another source reported an acute <br /> oral LD50 of greater than 5,000 mg/kg for 51.1%, 97%, and 98% sulfur. Also, there were no deaths <br /> of rats fed 98% sulfur at a single dose of 5,000 mg/kg (355). The intravenous rat LDIo (Lethal dose, <br /> low. The lowest dose which causes death in test animals.) was 8 mg/kg (354). The dermal LD50 for <br /> rats was greater than 5,000 mg/kg (223). The acute inhalation LC50 for 98% sulfur in rats is greater <br /> than 2.56 mg/1; and greater than 5.74 mg/I for 80 % sulfur(355). The oral LDIo for sulfur in rabbits <br /> was 175 mg/kg (354). The acute dermal LD50 in rabbits was greater than 2,000 mg/kg at 51.1%, <br /> 97%, and 98% sulfur. Also, there were no deaths of rabbits fed 98% sulfur at a single dose of 2,000 <br /> mg/kg (355, 359). A rabbit eye irritation test indicated all irritation had cleared 6 days after 98% <br /> sulfur was administered (355). The intraperitoneal LDIo was 55 mg/kg for sulfur in guinea pigs <br /> (354). <br /> • Chronic Toxicity: Chronic exposure to elemental sulfur at low levels is generally recognized as <br /> safe. Epidemiological studies show that mine workers exposed to sulfur dioxide throughout their <br /> lives often had eye and respiratory disturbances, chronic bronchitis and chronic sinus effects. <br /> However, no known risks of oncogenic, teratogenic, or reproductive effects are associated with the <br /> use of sulfur. Also, sulfur has been shown to be non-mutagenic in microorganisms (357). Repeated <br /> or prolonged exposure to dust may cause irritation to the mucous membranes. Bronchopulmonary <br /> disease may occur which, after several years, may be complicated by emphysema and <br /> bronchiectasis. Early symptoms in sulfur miners often include upper respiratory tract catarrh, with <br /> cough and expectoration which is mucoid and may even contain granules of sulfur. Asthma is a <br /> frequent complication. The maxillary and frontal sinuses may be affected; involvement is usually <br /> bilateral and pansinuitis may occur (354). <br /> • Reproductive Effects: There are no known risks of reproductive hazards associated with sulfur <br /> (357, 358). <br /> • Teratogenic Effects: There are no known risks of teratogenic hazards associated with sulfur(357, <br /> 358). <br /> • Mutagenic Effects: No information currently available. <br /> • Carcinogenic Effects: There are no known risks of carcinogenic/oncogenic effects associated with <br /> the use of sulfur(354, 357). <br /> • Organ Toxicity: Pulmonary function may be reduced. Radiological examinations have revealed <br /> irregular opacities in the lungs and occasionally nodulation has been reported, but not true nodular <br /> fibrosis (354). <br /> • Fate in Humans and Animals: No information currently available. <br /> 2 of 4 5/15/00 10:1 1 AM <br />